1. Home
  2. AFG vs CYTK Comparison

AFG vs CYTK Comparison

Compare AFG & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Financial Group Inc.

AFG

American Financial Group Inc.

HOLD

Current Price

$139.13

Market Cap

11.9B

Sector

Finance

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$65.74

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFG
CYTK
Founded
1872
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
10.7B
IPO Year
1997
2004

Fundamental Metrics

Financial Performance
Metric
AFG
CYTK
Price
$139.13
$65.74
Analyst Decision
Hold
Strong Buy
Analyst Count
4
19
Target Price
★ $141.00
$89.26
AVG Volume (30 Days)
267.4K
★ 1.7M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
★ 2.72%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 5.28
N/A
Revenue
★ $8,174,000,000.00
$13,368,000.00
Revenue This Year
N/A
$7.37
Revenue Next Year
$4.44
$310.19
P/E Ratio
$26.22
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$123.09
$50.15
52 Week High
$150.02
$88.31

Technical Indicators

Market Signals
Indicator
AFG
CYTK
Relative Strength Index (RSI) N/A 27.60
Support Level N/A $59.10
Resistance Level N/A $67.04
Average True Range (ATR) 0.00 2.27
MACD 0.00 -0.58
Stochastic Oscillator 0.00 1.37

Price Performance

Historical Comparison
AFG
CYTK

About AFG American Financial Group Inc.

American Financial Group Inc is an insurance holding company. Through its subsidiaries, it is engaged in the property and casualty insurance business, focusing on specialized commercial products for businesses. The group operates through two segments: Property and Casualty Insurance, which generates maximum revenue, and Other. The Property and Casualty Insurance segment is further divided into different sub-segments, such as Property and transportation, Specialty casualty, and Specialty financial. These sub-segments offer insurance coverage for vehicles and commercial property, customized programs for small to mid-sized businesses, workers' compensation insurance, risk management insurance programs for lending and leasing institutions, trade credit insurance, and other insurance products.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: